Other substances

P2,P3 Ketoamide derivative

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

P2,P3 Ketoamide derivative on PubChem

Synonyms

α-KI

 

Structure image - P2,P3 Ketoamide derivative

CN(C)S(=O)(=O)NCCCC[C@@H](C(=O)C(=O)NCC1=CN=CC=C1)NC(=O)OCC2(CCC2)CC3=CC=C(C=C3)F

Supporting references

Link Tested on Impact factor Notes Publication date
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2–P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach
3CLpro Small molecule In silico 		in silico 2.08

Predicted to bind the SARS-CoV-2 3C-like protease.

 Sep/02/2020

AI-suggested references

Link Publication date
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 alpha-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.
Sep/02/2020
Export (.csv)